German Pharmaceuticals & Biotech Potentially Undervalued Companies

Genmab

Market Cap: €108.9b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Avantor

Market Cap: €8.5b

Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.

Merck KGaA

Market Cap: €46.8b

Operates as a science and technology company in Germany.

Ono Pharmaceutical

Market Cap: €808.0b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Anika Therapeutics

Market Cap: €124.9m

A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.

Novo Nordisk

Market Cap: €1.7t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

HLS Therapeutics

Market Cap: €178.0m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Mochida Pharmaceutical

Market Cap: €114.0b

Manufactures and sells pharmaceuticals and healthcare products in Japan.

Champions Oncology

Market Cap: €87.6m

A technology-enabled research company, provides technology solutions for drug discovery and development in the United States.

Bristol-Myers Squibb

Market Cap: €93.9b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Medicure

Market Cap: €11.5m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Genetic Analysis

Market Cap: €58.7m

A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.

Illumina

Market Cap: €15.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Beijing Tong Ren Tang Chinese Medicine

Market Cap: €7.6b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

Medpace Holdings

Market Cap: €14.0b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Novartis

Market Cap: €187.2b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Magle Chemoswed Holding

Market Cap: €413.0m

Engages in research and development of pharmaceutical and medical device products in Sweden.

Vext Science

Market Cap: €71.8m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Zoetis

Market Cap: €65.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Danaher

Market Cap: €138.2b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Haleon

Market Cap: €30.5b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Ultragenyx Pharmaceutical

Market Cap: €2.8b

A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.

Christina Lake Cannabis

Market Cap: €11.2m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Annovis Bio

Market Cap: €45.2m

A clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States.

Thermo Fisher Scientific

Market Cap: €178.5b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

ANI Pharmaceuticals

Market Cap: €1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Citius Pharmaceuticals

Market Cap: €15.5m

A biopharmaceutical company, focuses on the development and commercialization of critical care products.

Pherecydes Pharma Société anonyme

Market Cap: €14.4m

Pherecydes Pharma Société anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Verano Holdings

Market Cap: €550.0m

Operates as a vertically integrated multi-state cannabis operator in the United States.

ANI Pharmaceuticals

Market Cap: €1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

Swedish Orphan Biovitrum

Market Cap: €95.8b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

Dynavax Technologies

Market Cap: €1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Abera Bioscience

Market Cap: €118.2m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Bio-Rad Laboratories

Market Cap: €7.4b

Manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

Aurora Cannabis

Market Cap: €389.0m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.